HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA of Epithelial to Mesenchymal Transition in Fuchs' Endothelial Corneal Dystrophy.

AbstractAIM:
a review of miRNA expression connected to epithelial mesenchymal transition studies in Fuchs' endothelial corneal dystrophy (FECD).
METHODS:
literature search strategy-PubMed central database, using "miRNA" or "microRNA" and "epithelial mesenchymal transition" or "EMT" and "Fuchs' endothelial corneal dystrophy" or "FECD" as keywords. Experimental or clinical studies on humans published in English regarding miRNA profiles of epithelial mesenchymal transition in Fuchs' endothelial corneal dystrophy published between 2009 and 2022 were included.
CONCLUSION:
The publications regarding the miRNA profiles of epithelial mesenchymal transition in Fuchs' endothelial corneal dystrophy are scarce but provide some valuable information about the potential biomarkers differentiating aging changes from early disease stages characterized by epithelial mesenchymal transition. In the corneal tissue of FECD patients, miRNA-184 seed-region mutation as well as unidirectional downregulation of total miRNA expression led by the miRNA-29 were demonstrated. For early diagnostics the miRNA of epithelial mesenchymal transition in aqueous humor should be analyzed and used as biomarkers.
AuthorsSpela Stunf Pukl
JournalGenes (Genes (Basel)) Vol. 13 Issue 10 (Sep 23 2022) ISSN: 2073-4425 [Electronic] Switzerland
PMID36292595 (Publication Type: Journal Article, Review)
Chemical References
  • MicroRNAs
Topics
  • Humans
  • MicroRNAs (genetics, metabolism)
  • Epithelial-Mesenchymal Transition (genetics)
  • Fuchs' Endothelial Dystrophy (genetics, metabolism)
  • Cornea

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: